Trial Profile
Telaprevir-associated skin eruptions in clinical practice in patients with chronic hepatitis C.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions
- 24 Aug 2015 New trial record